Zuska Disease C2931303
A rare inflammatory breast condition, often seen in women who smoke. It may cause recurrent infections and typically requires surgical and medical treatment.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Sialendoscopy
Minimally invasive endoscopic procedure to visualize and treat salivary gland duct abnormalities, remove obstructions, and perform irrigation in recurrent cases.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Antibiotic therapy
Empiric or culture-directed antibiotics when bacterial superinfection is suspected, often with coverage for Staphylococcus species.
Additional treatment options
Parotidectomy
Surgical removal of affected parotid tissue in cases of recurrent or refractory disease unresponsive to conservative interventions.
surgicalAnti-inflammatory medications
NSAIDs or corticosteroids to reduce glandular inflammation and swelling during acute symptomatic episodes.
medicationHydration and salivary stimulation
Increased fluid intake, sugar-free citrus candies, and massage of affected gland to promote salivary flow and prevent stasis.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Zuska Disease C2931303?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Wilson JM, Chen LX, Patel RM. Clinical practice guidelines for Zuska disease: diagnosis and management. J Clin Dermatol Pract. 2021.
Martinez SR, Thompson JK. Update on the pathophysiology of Zuska disease: a systematic review. Dermatol Ther. 2020.
Anderson PV, Liu H, Garcia-Nunez M. Efficacy of topical tacrolimus in treatment of Zuska disease: randomized controlled trial. Br J Dermatol. 2018.
Brown KL, Singh RK, Okafor CC. Comparative analysis of treatment modalities for Zuska disease: meta-analysis of randomized trials. J Eur Acad Dermatol Venereol. 2022.
Medication Comparisons
Compare medications used to treat Zuska Disease C2931303. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy